Ancora Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-10,638
Closed -$1.88M 1507
2020
Q1
$1.88M Buy
10,638
+8,180
+333% +$1.54M 0.09% 230
2019
Q4
$470K Hold
2,458
0.02% 504
2019
Q3
$414K Buy
+2,458
New +$400K 0.02% 488
2019
Q2
Sell
-1,366
Closed -$200K 634
2019
Q1
$200K Sell
1,366
-1,187
-46% -$172K 0.01% 564
2018
Q4
$342K Buy
2,553
+933
+58% +$153K 0.02% 480
2018
Q3
$309K Buy
1,620
+42
+3% +$7.72K 0.01% 577
2018
Q2
$263K Sell
1,578
-414
-21% -$66.5K 0.01% 610
2018
Q1
$336K Sell
1,992
-294
-13% -$49.3K 0.02% 551
2017
Q4
$374K Sell
2,286
-1,738
-43% -$312K 0.02% 491
2017
Q3
$825K Buy
4,024
+934
+30% +$217K 0.05% 361
2017
Q2
$751K Hold
3,090
0.05% 358
2017
Q1
$739K Sell
3,090
-1,500
-33% -$349K 0.05% 356
2016
Q4
$964K Buy
4,590
+1,890
+70% +$392K 0.07% 297
2016
Q3
$622K Sell
2,700
-53
-2% -$13K 0.06% 302
2016
Q2
$636K Buy
+2,753
New +$635K 0.07% 279

Other funds holding AGN

Ancora Advisors's AGN Position: Q2 2020 in Review

Ancora Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 10,638 shares — an estimated $1.88M sold.

Ancora Advisors first reported a position in AGN in Q2 2016 and held it in 15 quarters. The position peaked at $1.88M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Ancora Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Ancora Advisors sold 10,638 Allergan plc shares in Q2 2020, an estimated $1.88M.
  • Ancora Advisors first reported a position in Allergan plc in Q2 2016 and held it in 15 quarters.
  • Ancora Advisors's Allergan plc position peaked at $1.88M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Ancora Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.